Quick Read – QTUM outpaced IONQ 54% to 30% year to date, spreading risk across 85 quantum holdings including IonQ for just a 0.40% annual fee. – IonQ shareholders gain zero exposure to IBM’s and Microsoft’s competing quantum programs, concentrating all risk on a single…
apped-ion architecture. – IonQ’s 755% revenue surge masks a projected $320M EBITDA loss and $151M quarterly cash burn, making it a venture-style position. – Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and IonQ didn’t make the cut. Grab the names FREE today
Anyone who bought IonQ (NYSE:IONQ) bought a specific thesis: that trapped-ion architecture will win the race to commercial quantum computing. The stock rewards conviction when headlines break the right way and punishes it just as fast when they don’t. IonQ shares moved from $29.15 to $57.45 inside a six-month window in 2025, the kind of range that makes a single-name quantum position closer to a venture-style position than a diversified portfolio holding.
For investors who want exposure to the theme without that concentration, the Defiance Quantum ETF (NASDAQ:QTUM) owns the entire field, including IonQ, at a 0.40% expense ratio. Why holders bought IonQ in the first place The fundamental case is real. IonQ posted Q1 2026 revenue of $64.67 million, up 755% year over year, and raised full-year guidance to $260 million to $270 million.